Zalutumumab in Combination With Chemotherapy and Radiotherapy in Head and Neck Cancer

Clinical trial NCT00401401 · TERMINATED

Trial details

NCT number: NCT00401401
Sponsor: Genmab
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Head and Neck Cancer Squamous Cell Cancer

Start date: 2006-12-01
Primary completion: 2010-10-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.